PCSK9 and cardiovascular disorder: Together, the data presented in this study suggest that in addition to its anti-obesogenic and anti-steatotic effect, ME significantly improves serum lipid profile and reduces levels of pro-atherogenic PCSK9, which likely attenuates the risk of cardiovascular disease.